Associate Professor Katrina Spilsbury

Associate Professor
BSc, PhD, GradDipEpi, MBiostats

katrina.spilsbury@nd.edu.au
Phone: 08 9433 0859

  • Biography

    Katrina originally trained as a molecular biologist, completing postdoctoral training in a French immunology laboratory, and then worked on developing gene therapy to treat eye disease.  She switched focus to public health and completed a Masters of Biostatistics in 2008.  She has over 23 years’ experience using population-level linked data to investigate the epidemiology and patient health outcomes of a diverse range of health conditions. Katrina was part of the first ever Australian study that involved cross-jurisdictional linkage of hospital and death records across four states.  She has extensive experience in longitudinal and time to event analysis of large cross-jurisdictional data sets including PBS and Medicare data linked to state-based data collections.

  • Research expertise and supervision

    She is currently collaborating with clinical and academic teams based at the University of Queensland and University of Western Australia as an investigator on several NHMRC funded projects involving data linked across jurisdictions and a clinical trial. Katrina has also collaborated with clinicians from a wide range of medical disciplines ranging from otorhinolaryngology, oncology, urology, ophthalmology, psychiatry, general practice, gynaecology, burns, neurology and gastroenterology to investigate health outcomes. As a biostatistician with linked data analysis experience, she has mentored numerous students and staff in a less formal role over the years and formally supervised honours, masters and PhD students.

  • Journal articles and proceedings

    • Truter P, Flanagan P, Waller R, Richards K, Makate M, Johnstone A, Bongiascia L, Spilsbury K, Cavalheri V, Lin I: Short waits, happy patients and expert care, moving basic musculoskeletal care from the emergency department to a physiotherapist-led diversion pathway. Emerg Med Australas 2024.
    • Allanson ER, Copson S, Spilsbury K, Criddle S, Jennings B, Doherty DA, Wong AM, Dickinson JE: Second trimester maternal serum progesterone and estradiol concentrations with live and demised fetuses: Secondary analysis results from a randomized controlled trial. Reproductive, Female and Child Health 2024, 3(1):e77.
    • Ali S, Coory M, Donovan P, Na R, Pandeya N, Pearson SA, Spilsbury K, Tuesley K, Jordan SJ, Neale RE: Predicting the risk of pancreatic cancer in women with new-onset diabetes mellitus. J Gastroenterol Hepatol 2024.
    • Ali S, Coory M, Donovan P, Na R, Pandeya N, Pearson SA, Spilsbury K, Stewart LM, Thompson B, Tuesley K et al: Association between unstable diabetes mellitus and risk of pancreatic cancer. Pancreatology 2024, 24(1):66-72.
    • Tuesley KM, Spilsbury K, Webb PM, Protani MM, Dixon-Suen S, Pearson SA, Donovan P, Coory MD, Steer CB, Stewart LM et al: Association between antihypertensive medicine use and risk of ovarian cancer in women aged 50 years and older. Cancer Epidemiol 2023, 86:102444.
    • Spilsbury K, Tuesley KM, Pearson SA, Coory MD, Donovan P, Steer CB, Stewart LM, Pandeya N, Jordan SJ: Perioperative Beta-Blocker Supply and Survival in Women With Epithelial Ovarian Cancer and a History of Cardiovascular Conditions. J Clin Oncol 2023, 41(2):266-275.
    • Nolan J, Godecke E, Spilsbury K, Wu A, Singer B: Accuracy of the Australian National Sub-Acute and Non-Acute Patient Classification in predicting rehabilitation length of stay for stroke survivors who are >/=65 years of age and have lateropulsion. Top Stroke Rehabil 2023, 30(2):203-211.
    • Nolan J, Godecke E, Spilsbury K, Singer B: Post-Stroke Lateropulsion: Resolution and Function After Discharge From Inpatient Rehabilitation - A Cohort Study. Physiother Can 2023, 75(3):264-268.
    • Nolan J, Godecke E, Spilsbury K, Singer B: Post-Stroke Lateropulsion: Resolution and Function After Discharge From Inpatient Rehabilitation - A Cohort Study. Physiother Can 2023, 75(3):264-268.
    • Vaz S, Hang JA, Codde J, Bruce D, Spilsbury K, Hill AM: Prescribing tailored home exercise program to older adults in the community using a tailored self-modeled video: A pre-post study. Front Public Health 2022, 10:974512.
    • Tuesley KM, Webb PM, Protani MM, Spilsbury K, Pearson SA, Coory MD, Donovan P, Steer C, Stewart LM, Pandeya N et al: Response to Lehrer and Rheinstein. J Natl Cancer Inst 2022, 114(10):1427-1428.
    • Tuesley KM, Webb PM, Protani MM, Spilsbury K, Pearson SA, Coory MD, Donovan P, Steer C, Stewart LM, Pandeya N et al: Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older. J Natl Cancer Inst 2022, 114(6):878-884.
    • Nolan J, Godecke E, Spilsbury K, Singer B: Post-stroke lateropulsion and rehabilitation outcomes: a retrospective analysis. Disabil Rehabil 2022, 44(18):5162-5170.
    • Halkett GKB, Lobb E, Spilsbury K, Dhillon H, Nowak AK: Brain cancer patients' levels of distress and supportive care needs over time. Psychooncology 2022, 31(12):2074-2085.
    • Arendts G, Chenoweth L, Hayes BJ, Campbell E, Agar M, Etherton-Beer C, Spilsbury K, Howard K, Braitberg G, Cubitt M et al: CELPI: trial protocol for a randomised controlled trial of a Carer End of Life Planning Intervention in people dying with dementia. BMC Geriatr 2022, 22(1):869.
    • Ali S, Na R, Tuesley K, Spilsbury K, Stewart LM, Coory M, Webb PM, Donovan P, Pearson SA, Jordan SJ et al: The association between diabetes mellitus of different durations and risk of pancreatic cancer: an Australian national data-linkage study in women. Cancer Epidemiol 2022, 81:102266.
    • Janmohamed M, Lawn N, Spilsbury K, Chan J, Dunne J: Starting a new anti-seizure medication in drug-resistant epilepsy: Add-on or substitute? Epilepsia 2021, 62(1):228-237.
    • Allanson ER, Copson S, Spilsbury K, Criddle S, Jennings B, Doherty DA, Wong AM, Dickinson JE: Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation: A Randomized Controlled Trial. Obstet Gynecol 2021, 137(5):801-809.
    • Ye L, Mesbah Ardakani N, Thomas C, Spilsbury K, Leslie C, Amanuel B, Millward M: Detection of Low-level EGFR c.2369 C > T (p.Thr790Met) Resistance Mutation in Pre-treatment Non-small Cell Lung Carcinomas Harboring Activating EGFR Mutations and Correlation with Clinical Outcomes. Pathol Oncol Res 2020, 26(4):2371-2379.
    • Stewart LM, Stewart CJR, Spilsbury K, Cohen PA, Jordan S: Association between pelvic inflammatory disease, infertility, ectopic pregnancy and the development of ovarian serous borderline tumor, mucinous borderline tumor and low-grade serous carcinoma. Gynecol Oncol 2020, 156(3):611-615.
    • Mai L, Spilsbury K, Edgar DW, Berghuber A, Wood FM: Increased risk of blood transfusion in patients with diabetes mellitus sustaining non-major burn injury. Burns 2020, 46(4):888-896.
    • DeJong H, Abbott S, Zelesco M, Spilsbury K, Ziman M, Kennedy BF, Martin L, Wood FM: Objective quantification of burn scar stiffness using shear-wave elastography: Initial evidence of validity. Burns 2020, 46(8):1787-1798.
    • DeJong H, Abbott S, Zelesco M, Spilsbury K, Martin L, Sanderson R, Ziman M, Kennedy BF, Wood FM: A Novel, Reliable Protocol to Objectively Assess Scar Stiffness Using Shear Wave Elastography. Ultrasound Med Biol 2020, 46(7):1614-1629.
    • Powell A, Cohen PA, Spilsbury K, Steel N, Blomfield P: RANZCOG Fellows' adherence to guidelines following cytological prediction of cervical adenocarcinoma-in-situ: Cause for concern? Aust N Z J Obstet Gynaecol 2019, 59(2):294-300.
    • Gips E, Spilsbury K, Boecker C, Ng R, Arendts G: Do frailty and comorbidity indices improve risk prediction of 28-day ED reattendance? Reanalysis of an ED discharge nomogram for older people. Aging Clin Exp Res 2019, 31(10):1401-1406.